Sumitomo Mitsui Trust Group Inc. lowered its position in Celsius Holdings, Inc. (NASDAQ:CELH – Free Report) by 2.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 283,061 shares of the company’s stock after selling 7,544 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned about 0.12% of Celsius worth $8,877,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently made changes to their positions in the company. GSA Capital Partners LLP increased its stake in shares of Celsius by 21.8% during the third quarter. GSA Capital Partners LLP now owns 28,136 shares of the company’s stock valued at $882,000 after acquiring an additional 5,038 shares during the period. Venturi Wealth Management LLC acquired a new position in shares of Celsius during the third quarter valued at approximately $55,000. Crossmark Global Holdings Inc. increased its stake in shares of Celsius by 8.4% during the third quarter. Crossmark Global Holdings Inc. now owns 10,723 shares of the company’s stock valued at $336,000 after acquiring an additional 834 shares during the period. Covestor Ltd increased its stake in shares of Celsius by 35.4% during the third quarter. Covestor Ltd now owns 5,978 shares of the company’s stock valued at $187,000 after acquiring an additional 1,564 shares during the period. Finally, Bridges Investment Management Inc. increased its stake in shares of Celsius by 15.0% during the third quarter. Bridges Investment Management Inc. now owns 16,783 shares of the company’s stock valued at $526,000 after acquiring an additional 2,186 shares during the period. Institutional investors and hedge funds own 60.95% of the company’s stock.
Celsius Stock Performance
NASDAQ CELH opened at $25.66 on Monday. The firm’s 50 day moving average price is $31.41 and its two-hundred day moving average price is $49.47. Celsius Holdings, Inc. has a twelve month low of $25.50 and a twelve month high of $99.62. The stock has a market cap of $6.03 billion, a price-to-earnings ratio of 35.64, a PEG ratio of 2.95 and a beta of 1.86.
Insider Activity
Analyst Upgrades and Downgrades
A number of research analysts recently commented on the stock. LADENBURG THALM/SH SH lowered their price objective on shares of Celsius from $72.00 to $68.00 and set a “neutral” rating on the stock in a research note on Monday, October 21st. Bank of America lowered their price objective on shares of Celsius from $32.00 to $26.00 and set an “underperform” rating on the stock in a research note on Thursday, September 5th. Piper Sandler decreased their price target on shares of Celsius from $50.00 to $47.00 and set an “overweight” rating on the stock in a research report on Tuesday, September 24th. Truist Financial lifted their price target on shares of Celsius from $30.00 to $35.00 and gave the stock a “hold” rating in a research report on Wednesday, October 16th. Finally, Maxim Group decreased their price target on shares of Celsius from $65.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, September 5th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $54.40.
Check Out Our Latest Report on Celsius
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Articles
- Five stocks we like better than Celsius
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- The Significance of Brokerage Rankings in Stock Selection
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.